Weedmaps 4Q21: Reinvesting Most of the EBITDA

by | Feb 24, 2022 | Company Analysis, Earnings Report

Weedmaps reported 4Q21 earnings (presentation) and updated guidance for 2022; revenue beat the reduced expectations of 3Q21, revenue guidance for 2022 was reiterated, while profitability guidance was significantly lower than expected as the company increases investments to drive growth in 2023.

The stock traded up 14% after hours to $5.00 on Wednesday 2/23, but what does the shift really mean?

Premium Members can read our thoughts below and download an updated working model that delineates customers vs revenue per customer, separate cost line items, and the balance sheet.

[Download not found]